Literature DB >> 7686791

Effects of the recombinant hematopoietic growth factors interleukin-3, interleukin-6, stem cell factor, and leukemia inhibitory factor on the megakaryocytic differentiation of CD34+ cells.

N Debili1, J M Massé, A Katz, J Guichard, J Breton-Gorius, W Vainchenker.   

Abstract

Using a liquid culture system and human CD34+ marrow cells, we examined the effects of recombinant interleukin (IL)-3, IL-6, stem cell factor (SCF), and leukemia inhibitory factor (LIF) on megakaryocyte (MK) growth, endoreplication, and maturation. MK proliferation, ploidy distribution, and volume were studied by flow cytometry. IL-3 was the only cytokine that, alone, induced a marked increase in MK proliferation. At a high CD34+ cell concentration, addition of IL-6, SCF, and LIF to IL-3--containing medium increased the number of MK (approximately 20%). At a low CD34+ cell concentration, IL-3 alone was a less potent inducer of MK growth, but IL-6, SCF, and their combination had a marked effect, increasing the number of MK by a factor 1.7, 2.9, and 4.4, respectively. These differences may be related to the endogenous release of cytokines in the culture. The effects of these cytokines were subsequently tested on a more mature type of MK progenitor (CD34+ cells isolated after 6 days of incubation in liquid culture). IL-3 remained the most potent cytokine, but IL-6 or SCF alone also increased MK number in comparison to unstimulated cultures. The ploidy distribution of MKs grown with IL-3 was not markedly changed by the addition of the other cytokines, with the exception of SCF, which induced a significant increase in the mean ploidy. However, in all cultures, glycoprotein (GP)IIIa+ 2N and 4N cells were present in large but variable numbers (35% to 75%). The number of these low-ploidy MKs directly correlated with MK proliferation. Therefore, we subsequently explored the absolute number of polyploid MK produced in culture. SCF, IL-6, or their combination, in association with IL-3, increased the number of polyploid MK up to fourfold. In addition, they improved the maturation of MK grown in the presence of IL-3, leading to the synthesis of demarcation membranes and platelet shedding. A similar effect of growth factors on the maturation of day 6 CD34+ cells was observed. We conclude that IL-6 and SCF have a broad range of activities on megakaryocytopoiesis, acting both on the early and late stages. However, the proliferative properties of these cytokines largely predominate in our cultures. Therefore, in the absence of a specific MK regulator, this study further extends the need for a combination of growth factors to maximize megakaryocytopoiesis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7686791

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  20 in total

1.  Replating of bioreactor expanded human bone marrow results in extended growth of primitive and mature cells.

Authors:  B O Palsson; D J Oh; M R Koller
Journal:  Cytotechnology       Date:  1995-01       Impact factor: 2.058

2.  High platelet count as a link between renal cachexia and cardiovascular mortality in end-stage renal disease patients.

Authors:  Miklos Z Molnar; Elani Streja; Csaba P Kovesdy; Matthew J Budoff; Allen R Nissenson; Mahesh Krishnan; Stefan D Anker; Keith C Norris; Gregg C Fonarow; Kamyar Kalantar-Zadeh
Journal:  Am J Clin Nutr       Date:  2011-08-03       Impact factor: 7.045

3.  A new form of macrothrombocytopenia induced by a germ-line mutation in the PRKACG gene.

Authors:  Vladimir T Manchev; Morgane Hilpert; Eliane Berrou; Ziane Elaib; Achille Aouba; Siham Boukour; Sylvie Souquere; Gerard Pierron; Philippe Rameau; Robert Andrews; François Lanza; Regis Bobe; William Vainchenker; Jean-Philippe Rosa; Marijke Bryckaert; Najet Debili; Remi Favier; Hana Raslova
Journal:  Blood       Date:  2014-07-24       Impact factor: 22.113

4.  Cytokine production by a megakaryocytic cell line.

Authors:  B Sandrock; K M Hudson; D E Williams; M A Lieberman
Journal:  In Vitro Cell Dev Biol Anim       Date:  1996-04       Impact factor: 2.416

5.  The relationship between hematological parameters and prognosis of children with acute ischemic stroke.

Authors:  Ebru Yilmaz; Ayse Bayram Kacar; Adil Bozpolat; Gokmen Zararsiz; Burcu S Gorkem; Musa Karakukcu; Turkan Patiroglu; Hakan Gumus; Mehmet Akif Ozdemir; Alper Ozcan; Huseyin Per; Ekrem Unal
Journal:  Childs Nerv Syst       Date:  2017-12-05       Impact factor: 1.475

6.  Features associated with pulmonary arterial hypertension in Chinese hospitalized systemic lupus erythematosus patients.

Authors:  Shu-Zhen Xu; Xiang-Pei Li; Xiao-Mei Li; Zong-Wen Shuai; Rui-Xue Leng; Hai-Feng Pan; Dong-Qing Ye
Journal:  Clin Rheumatol       Date:  2018-03-08       Impact factor: 2.980

7.  Stem cell factor (SCF) synergizes with megakaryocyte colony stimulating activity in post-irradiated aplastic plasma in stimulating human megakaryocytopoiesis.

Authors:  V R Deutsch; A Eldor; T Olson; V Barak; M Pick; A Nagler
Journal:  Med Oncol       Date:  1996-03       Impact factor: 3.064

8.  Platelet volume indices in patients with coronary artery disease and acute myocardial infarction: an Indian scenario.

Authors:  M M Khandekar; A S Khurana; S D Deshmukh; A L Kakrani; A D Katdare; A K Inamdar
Journal:  J Clin Pathol       Date:  2006-02       Impact factor: 3.411

Review 9.  The causal role of megakaryocyte–platelet hyperactivity in acute coronary syndromes.

Authors:  John F Martin; Steen D Kristensen; Anthony Mathur; Erik L Grove; Fizzah A Choudry
Journal:  Nat Rev Cardiol       Date:  2012-11       Impact factor: 32.419

10.  Thrombopoietin, the Mp1 ligand, is essential for full megakaryocyte development.

Authors:  K Kaushansky; V C Broudy; N Lin; M J Jorgensen; J McCarty; N Fox; D Zucker-Franklin; C Lofton-Day
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.